Research Paper Volume 13, Issue 5 pp 7549—7569
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Figure 4. Forest plots of the number of platform crossings in the Morris water maze. Improvements were seen in (A) the d-gal injection model; (B) APP/PS1 transgenic mice; (C) the Aβ1-42 injection model in the ginsenoside Rg1 group compared with a control group.